Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesCardiovascular diseases and risk of hip fracture
JAMA, 10/23/09
Sennerby U et al. – A diagnosis of CVD was significantly associated with risk of subsequent hip fracture. Increased risks in co-twins without an index diagnosis suggest genetic factors in the association between CVD and osteoporotic fractures.
Methods- 31 936 Swedish twins born from 1914-1944 was followed up from age of 50 y
- National Patient Registry identified twins with CVDs and fractures from 1964 through 2005
- Time-dependent exposures using Cox proportional hazard regression models evaluated
- Crude absolute rate of hip fractures was 12.6 per 1000 person-years after diagnosis of HF, 12.6 per 1000 person-years after a stroke, 6.6 per 1000 person-years after diagnosis of peripheral atherosclerosis, and 5.2 per 1000 person-years after diagnosis of ischemic heart disease compared with 1.2 per 1000 person-years for those without CVD diagnosis
- Multivariable-adjusted hazard ratio (HR) of hip fracture after diagnosis of heart failure 4.40 ; after stroke, HR was 5.09 ; after diagnosis of peripheral atherosclerosis, HR was 3.20; and after ischemic heart disease event, HR was 2.32
- Identical twins without heart failure and stroke also had, after their co-twins had been exposed to respective diseases, an increased rate of hip fracture
- Sibling twins pseudoexposed for heart failure had multivariable-adjusted HR of 3.74 for hip fracture, whereas pseudoexposure for stroke had an HR of 2.29
Today in Bone Metabolism...keeping you current
Receive free subspecialty "5-minute updates" via email
Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: Clinicopathological features of 24 patients
Journal of Rheumatology, 11/09/09
Bisphosphonate therapy: When not to monitor BMD
The Journal of Family Practice, 11/02/09
Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Article Search
Sponsor